Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Le Dr Irina Zaidman se spécialise en greffe de moelle osseuse pédiatrique – un traitement essentiel de l'anémie aplasique – au centre médical Hadassah.
Réalisation de plus de 3 500 greffes de moelle osseuse – reconnu par Forbes comme l'un des meilleurs médecins en 2018.
Le professeur Bosch est un leader de renommée mondiale dans le domaine de la leucémie lymphoïde chronique (LLC), avec plus de 100 articles publiés et une participation continue à plus de 80 essais cliniques.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
Le Prof. Dr Serdar Bedii Omay a publié plus de 65 articles scientifiques sur l'hématologie – axés sur les traitements avancés à l'hôpital Emsey.
Le Dr Apak est spécialisé en hématologie-oncologie pédiatrique avec plus de 30 ans d'expérience, se concentrant sur la greffe de moelle osseuse et la thérapie par cellules CAR-T à l'hôpital universitaire de Biruni.
Le professeur associé Rafet Eren est spécialisé en hématologie, avec plus de 50 publications dans des revues internationales, témoignant d'une expertise approfondie des troubles sanguins.
Le Pr Fabio Ciceri dirige le service d'hématologie et de transplantation de moelle osseuse de l'hôpital de recherche San Raffaele, un centre spécialisé dans les thérapies avancées pour les troubles sanguins.
Le professeur Baytan est spécialisé en hématologie et oncologie pédiatriques, se concentrant sur les cancers de l'enfant et les greffes de moelle osseuse à l'hôpital Emsey.
Spécialisé dans la leucémie chronique et les maladies myéloprolifératives, le Dr Dogu apporte son expertise approfondie en hématologie au Liv Hospital Ulus.
Le professeur associé Ali Hakan Kaya est spécialisé en hématologie et en greffes de cellules souches, bénéficiant d'une formation approfondie dans les meilleurs hôpitaux turcs.
Le Dr Eduardo Fernandez est l'un des 50 experts certifiés en cellules souches au Mexique, reconnu pour ses connaissances avancées en médecine régénérative.
Spécialisée dans les troubles de l'insuffisance médullaire, le Dr Itir Sirinoglu Temiz dirige le service d'hématologie du Liv Hospital Vadistanbul.
Plus de 20 ans de spécialisation en hématologie pédiatrique – le Dr López-Ibor dirige l'unité d'hématologie et d'oncologie pédiatriques de HM Montepríncipe.